Section I
41 – 50 of 5045
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Exploring novel genomic biomarkers for response and survival after neoadjuvant chemotherapy and radical cystectomy of muscle-invasive bladder cancer
- Contribution to journal › Article
-
Mark
Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery : A multi-institutional retrospective cohort study
- Contribution to journal › Article
-
Mark
The multidimensional role of laminin γ2 (LAMC2) on cancer progression
- Contribution to journal › Scientific review
-
Mark
Kloka kliniska val och hälsoekonomiska utvärderingar
(2025) In Läkartidningen
- Contribution to journal › Debate/Note/Editorial
-
Mark
Digital och interaktiv palliativ mottagning
(2025) 10:e Nationella konferensen Palliativ vård
- Contribution to conference › Poster
-
Mark
Utveckling av kommunikativ och empatisk förmåga- en studentdriven modell i läkarutbildningen
(2025) 10:e Nationella konferensen Palliativ vård
- Contribution to conference › Poster
-
Mark
Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer : a nationwide population-based study
- Contribution to journal › Article
-
Mark
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden : LYMPHOMA
- Contribution to journal › Letter
-
Mark
Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort
- Contribution to journal › Article
-
Mark
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
- Contribution to journal › Article
